Le Lézard
Classified in: Health
Subjects: CCA, FVT

AbbVie to Host First-Quarter 2024 Earnings Conference Call


NORTH CHICAGO, Ill., April. 4, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2024 financial results on Friday, April 26, 2024, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas ? immunology, oncology, neuroscience, and eye care ? and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

AbbVie logo

 

SOURCE AbbVie


These press releases may also interest you

at 04:15
Fastest Labs Announces Expansion into Coastal North Carolina
Fastest Labs, a leading national drug, alcohol, and DNA testing company, is expanding its presence in North Carolina with a new franchise location in Wilmington, NC. The move marks a significant stride in the company's efforts to provide fast,...

at 04:15
New multi-stakeholder industry initiative launched in the UK to take collaborative action on recycling of primary pharmaceutical packaging
The Circularity in Primary Pharmaceutical Packaging Accelerator (CiPPPA) initiative launched this week to tackle the challenges of recycling medicinal devices and pharmaceutical packaging. The pharmaceutical industry faces recycling difficulties due...

at 04:06
Resource-Appropriate Cancer Care, Including Coexisting Health Issues of HIV and Cancer, to be Addressed During Meeting in Nairobi
Local and global experts are meeting in Nairobi, Kenya to update clinical practice guidelines as part of ongoing work with Allied Against Cancer?a collaboration between the National Comprehensive Cancer Network® (NCCN®), African...

at 04:00
Ellipses' next generation selective RET inhibitor EP0031/A400 cleared to start Phase 2
Ellipses Pharma Limited ("Ellipses"), a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model, announced today the U.S. Food and Drug Administration (FDA) has...

at 02:30
Pop-R&B Artist & International Award-Winning Classical Pianist Janet Noh Releases Critically Acclaimed 'Oh Child' Record and Film Production. 100% of Proceeds Are Being Donated to the Korean American Family Service Center, Supporting Survivors of Domestic Abuse.
On April 30th, 2024, in celebration of Mental Health Awareness Month and AAPI Heritage Month,  international award-winning classical pianist and pop-R&B singer Janet Noh released her newest record 'Oh Child' as well as its accompanying cinematic...

at 02:05
Epsilogen Appoints Ashley Nagle as Chief Business Officer and Peter Finan as Non-Executive Chairman as Part of Broader Company Expansion
Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces the appointments of Ashley Nagle as Chief Business Officer (CBO) and Peter Finan, currently a Non-Executive Director, as Non-Executive...

More news about Health...


News published on and distributed by: